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ABSTRACT  1 
Background - Obesity is a multifactorial condition influenced by genetics, lifestyle and 2 
environment.  3 
Objective - To investigate whether the association between a validated genetic profile risk 4 
score for obesity (GPRS-obesity) with body mass index (BMI) and waist circumference 5 
(WC) was modified by sleep characteristics. 6 
Design - This study included cross-sectional data from 119,859 white European adults, aged 7 
37-73 years, participating on the UK Biobank. Interactions between GPRS-obesity, and sleep 8 
characteristics (sleep duration, chronotype, day napping, and shift work) in their effects on 9 
BMI and WC were investigated.   10 
Results - The GPRS-obesity was associated with BMI (β:0.57 kg.m-2 per standard deviation 11 
(SD) increase in GPRS, [95%CI:0.55, 0.60]; P=6.3x10
-207) and WC (β:1.21 cm, [1.15, 1.28]; 12 
P=4.2x10
-289
). There were significant interactions between GPRS-obesity and a variety of 13 
sleep characteristics in their relationship with BMI (P-interaction <0.05). In participants who 14 
slept <7 hrs or >9 hrs daily, the effect of GPRS-obesity on BMI was stronger (β:0.60 [0.54, 15 
0.65] and 0.73 [0.49, 0.97] kg.m
-2
 per SD increase in GPRS, respectively) than in normal 16 
length sleepers (7-9 hours; β:0.52 [0.49, 0.55] kg.m-2 per SD). A similar pattern was observed 17 
for shiftworkers (β:0.68 [0.59, 0.77] versus 0.54 [0.51, 0.58] kg.m-2 for non-shiftworkers) and 18 
for night-shiftworkers (β:0.69 [0.56, 0.82] versus 0.55 [0.51, 0.58] kg.m-2 for non-night-19 
shiftworkers), for those taking naps during the day (β:0.65 [0.52, 0.78] versus 0.51 [0.48, 20 
0.55] kg.m
-2
 for those who never/rarely had naps) and for those with a self-reported evening 21 
chronotype (β:0.72 [0.61, 0.82] versus β:0.52 [0.47, 0.57] kg.m-2 for morning chronotype). 22 
Similar findings were obtained using WC as the outcome. 23 
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Conclusions – This study shows that the association between genetic risk for obesity and 24 
phenotypic adiposity measures is exacerbated by adverse sleeping characteristics.  25 
Key Words: Obesity, sleep, chronotype, nap, shiftwork, night-shiftworkers, genetic risk 26 
score, genes   27 
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INTRODUCTION  28 
Sleep is a fundamental behaviour, with growing evidence suggesting that certain sleep 29 
behaviours are a strong risk factor for obesity (1). Previous studies suggest a U-shaped 30 
relationship between sleep duration and obesity, whereby both short and long sleep duration 31 
are associated with higher risk of obesity (1, 2). Although less well studied, other sleep 32 
characteristics including chronotype (i.e. being an evening versus morning person)), daytime 33 
napping, and shift work (including night shift work) may also be associated with obesity (3-34 
5). 35 
The worldwide obesity epidemics, and its consequent effects on morbidity and mortality, are 36 
responsible for a large public health burden (6, 7). The dramatic increase in obesity 37 
prevalence over the past three decades has been attributed to changes in lifestyle in response 38 
to an “obesogenic” environment (8). However, obesity is a multifactorial condition 39 
influenced by lifestyle and environment, as well as by genetics (8). It has a largely polygenic 40 
genetic architecture and its heritability is approximately 40-70% (8). However, the fact that 41 
obesity prevalence varies throughout the world and is changing over timescales too short to 42 
be influenced by changing risk allele frequencies, suggests that there may be gene-43 
environment interactions and that genetic risk is moderated by lifestyle/environment. The 44 
remaining unexplained heritability may be accounted for in part by such unappreciated 45 
gene/environment interactions (9). Some genetic factors may operate independently of 46 
environment, but others may confer greater predisposition to weight gain in an obesogenic 47 
environment (10), a hypothesis supported by the results of twin studies of changes in 48 
adiposity in response to environmental influences (11). 49 
Thus far, there is growing evidence regarding the contribution of genetic factors on different 50 
sleep-related characteristics (12). However, there is limited evidence on genotype-lifestyle 51 
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interactions in the area of obesity and circadian biology. No studies have yet investigated 52 
whether overall genetic predisposition to obesity, as measured using genetic profile risk 53 
scores for obesity (GPRS-obesity), interacts with sleep characteristics, such as sleep duration, 54 
chronotype, day napping, and shift work, to influence adiposity. In the current study, we 55 
therefore investigated whether the associations between of a comprehensive and validated 56 
GPRS-obesity (13) with adiposity outcomes were modulated by sleep-related characteristics 57 
in the UK Biobank cohort, a large population sample. 58 
 59 
SUBJECTS AND METHODS 60 
Study design 61 
Between April 2007 and December 2010, UK Biobank recruited 502,549 participants (5.5% 62 
response rate), aged 37-73 years from the general population (14). Participants attended one 63 
of 22 assessment centres across England, Wales and Scotland (15) where they completed a 64 
touch-screen questionnaire (including self-reported sleep duration, chronotype, day napping, 65 
shiftwork and nightshift work), had physical measurements taken and provided biological 66 
samples, as described in detail elsewhere (15). Of these participants, 119,859 had genotype 67 
data available for the GPRS-obesity SNPs used in this study after exclusions, detailed below, 68 
due to quality control, relatedness, mismatching of reported gender and genetically estimated 69 
sex, and non-white ethnicity. The number of participants with data on sleep characteristics 70 
(and genotype data) was as follows: sleep duration - 498,463 (115,139); chronotype - 444,331 71 
(37,016); day napping - 500,784 (115,646); shiftwork - 286,522 (65,491).  72 
The outcome measures considered were BMI and waist circumference (WC). The 73 
independent predictor variable of interest was a genetic profile risk score for BMI (GPRS-74 
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obesity). Sleep duration, chronotype, day napping, shift work, and nightshift work were 75 
treated as potential moderators.  76 
Ethics 77 
UK Biobank received ethical approval from the North West Multi-centre Research Ethics 78 
Committee (REC reference: 11/NW/03820).  All participants gave written informed consent 79 
before enrolment in the study, which was conducted in accord with the principles of the 80 
Declaration of Helsinki.   81 
Procedures 82 
At baseline assessment, sleep, socio-demographic and lifestyle variables were collected from 83 
all participants using a self-completed, touch-screen questionnaire. Self-reported sleep 84 
duration was obtained using the following question "About how many hours sleep do you get 85 
in every 24 hours?”. Sleep duration was used to derived sleep categories including short 86 
sleeper (<7 h.day
-1
), normal sleepers (between 7 and 9 h.day
-1
) and long sleepers (>9 h.day
-1
). 87 
Chronotype was self-reported and collected using the following question "Do you consider 88 
yourself to be?" a) Definitely a 'morning' person; b) more morning than evening; c) more 89 
evening than morning; and d) Definitely an 'evening' person. We restricted our analyses to 90 
individuals in categories a) and d) to robust phenotyping for chronotype, in line with previous 91 
analyses on the UK Biobank cohort (16). Daytime napping was self-reported and participants 92 
were asked “Do you have a nap during the day?” with the responses being a) Never/rarely; b) 93 
Sometimes; or c) Usually. Shift work and night shift work variables were also self-reported 94 
and collected using the questions "Does your work involve shift work?” and "Does your work 95 
involve night shifts?" with responses of a) Never/rarely; b) Sometimes; c) Usually; or d) 96 
Always; for this study we recoded answers into two categories for both shift-related variables 97 
“Never/rarely” and “Yes” which include “sometimes”; “usually” and “always”.  98 
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Self-reported physical activity was recorded using a self-completed questionnaire based on 99 
the International Physical Activity Questionnaire (IPAQ) short form (17). Physically active 100 
individuals were defined as those who met the recommendation of at least 600 METs.min
-101 
1
.week
-1
 of moderate or vigorous PA (17). Total time spent in sedentary behaviour (h.week
-1
) 102 
was estimated as the sum of self-reported time spent driving, using a computer and watching 103 
television (TV).  104 
Dietary information was collected via a self-reported dietary frequency questionnaire (Oxford 105 
WebQ) (18). Area-based socioeconomic status was defined from postcode of residence using 106 
the Townsend score (19). Age was calculated from dates of birth and baseline assessment. 107 
Medical history (physician diagnosis of depression, longstanding illness, diabetes, CVD, and 108 
cancer) was collected from the self-completed, baseline questionnaire. Height and body 109 
weight were measured by trained nurses during the initial assessment centre visit. BMI was 110 
calculated from weight/height
2
 and the WHO criteria (20) used to classify BMI into 111 
categories: underweight <18.5, normal weight 18.5-24.9, overweight 25.0-29.9 and obese 112 
≥30.0 kg.m-2. Further details of these measurements can be found in the UK Biobank online 113 
protocol (http://www.ukbiobank.ac.uk).  114 
Genetic data analysis 115 
For this study, we used the first genetic data release (June 2015), which included 116 
approximately one-third of the UK Biobank participants (n=152,770). Aiming to maximize 117 
homogeneity and GPRS-obesity applicability, we restricted the sample to those who reported 118 
being of white UK ancestry and for whom BMI phenotype data were available. 119 
Approximately 67% of this sample was genotyped using the Affymetrix UK Biobank Axiom 120 
array (Santa Clara, CA, USA) and the remaining 33% were genotyped using the Affymetrix 121 
UK BiLEVE Axiom array. The two arrays share over 95% marker content. Further 122 
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information on the genotyping process is available on the UK Biobank website 123 
(http://www.ukbiobank.ac.uk/scientists-3/genetic-data), which includes detailed technical 124 
documentation (http://www.ukbiobank.ac.uk/wp-125 
content/uploads/2014/04/UKBiobank_genotyping_QC_documentation-web.pdf).  126 
We deployed a standard set of sample quality control procedures and excluded participants 127 
on the basis of sample failure (Biobank Data Dictionary item #22010: UK Biobank genomic 128 
analysis exclusions), relatedness (#22012: genetic relatedness factor; a random member of 129 
each pair of individuals with KING-estimated kinship coefficient >0.0442 was removed), 130 
gender mismatch (#22001 derived from genotype analysis and self-reported sex), ethnicity 131 
(non-white Europeans were removed from the analysis based on self-reported ethnicity) and 132 
quality control failure in the UK BiLEVE study (#22050: UK BiLEVE Affymetrix quality 133 
control for samples and #22051: UK BiLEVE genotype quality control for samples). This left 134 
119,859 of whom 119,679 had BMI data available. 135 
GPRS-obesity was derived from a set of 93 SNPs that was in turn derived from the 97 136 
genome-wide significant BMI-associated SNPs reported by Locke and colleagues (13). (See 137 
Supplemental Table 1). 95 of these 97 SNPs were genotyped in the UK Biobank cohort (the 138 
two missing SNPs were rs2033529 and rs12016871), while two further SNPs (rs9925964 and 139 
rs17001654) were excluded on the basis of deviation from Hardy-Weinberg equilibrium (P 140 
<1 x 10
-6
) as assessed with PLINK (21); there were no proxy SNPs (r>0.8) within the UK 141 
Biobank dataset. We constructed an externally-weighted GPRS-obesity for each participant, 142 
weighted by the per allele effect size estimates reported in the GIANT consortium study (beta 143 
per one-SD unit of BMI) (13) and calculated according to the procedure given in the PLINK 144 
manual (http://pngu.mgh.harvard.edu/~purcell/plink/profile.shtml), using the -no-mean-145 
imputation flag. GPRS-obesity values were normally distributed across the UK Biobank 146 
cohort.  147 
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Statistical analyses 148 
Baseline phenotypic and morbidity data were used in the analyses. General linear models 149 
(GLM) were used to test for associations between GPRS-obesity and the outcomes (BMI and 150 
WC). The GPRS was transformed to a z-score before use in models, so data are presented as 151 
BMI or WC changes per SD increase in GPRS. Associations between GPRS and BMI/WC 152 
categories (BMI ≥25.0 kg.m-2; BMI ≥30.0 kg.m-2; centrally-obese: WC ≥88 cm for women 153 
and ≥102 cm for men) were investigated using binary logistic regression, with the lower 154 
adiposity category treated as the referent. 155 
Interactions between sleep characteristics and the GPRS-obesity in the association with the 156 
outcome measures (BMI and WC) were investigated using GLM. For this the interaction 157 
terms for sleep characteristics (sleep duration categories, chronotype, day napping, shift 158 
work, and nightshift work), were fitted treating all sleep factors as categorical variables and 159 
GPRS-obesity as a continuous variable. Where interactions were statistically significant, 160 
stratified analyses were undertaken for each sleep variable.  161 
For each of the approaches described above, we ran two incremental models that included an 162 
increasing number of covariates: “model 0” included age, sex, month of recruitment, 163 
deprivation score, medical history (diabetes, long-standing illness, CVD, cancer, and 164 
depression), and genetic principal components variables; “model 1” included all variables in 165 
model 0, but also adjusted for smoking status, portions of food categories eaten per day 166 
(alcohol, fruit, coffee, vegetables, meats, processed meat, cereals, bread, and cheese), and 167 
total physical activity, as well as sedentary behaviours and sleep characteristic (sleep 168 
duration, chronotype, and day napping) when these were not being tested as potential effect 169 
modifiers. All analyses were performed using STATA 14 statistical software (StataCorp LP). 170 
 171 
12 
 
12 
 
RESULTS 172 
The main characteristics of the participants by GPRS-obesity quartile, and sleep 173 
characteristics are summarised in Tables 1 and 2 and Supplemental Tables 2-5, respectively. 174 
In summary, 52.6% of the cohort was female, mean age was 56.9 years, 12.3% were current 175 
smokers, 67.6% were overweight or obese, and 34.5% were centrally obese. Based on self-176 
report, 54% of the participants were physically active (>600 MET.min
-1
.week
-1
), 24.3% had 177 
short sleep duration (<7 h.day
-1
) and 1.8% had long sleep duration (>9 h.day
-1
), 25.4% had 178 
evening chronotype, 5.5% usually napped during the day, 16.9% did shift work and 9.4% 179 
nightshift work. All sleep characteristics were significantly associated with BMI and WC 180 
(Table 3). 181 
Genetic profile risk score and obesity measures 182 
GPRS-obesity explained 1.9% and 1.1% of the variance in BMI and WC, respectively, with 183 
greater genetic risk being associated with a higher BMI (β:0.57 kg.m-2 increase per SD 184 
change in GPRS-obesity [95%CI:0.55, 0.60], p=6.3x10
-207
) and greater WC (β:1.21 cm per 185 
GPRS-obesity SD [95%CI:1.15, 1.28], p=4.2x10
-289
). After adjustment for socio-186 
demographic factors, medical history, total sedentary behaviour, dietary intake, and sleep 187 
characteristics, these associations were marginally attenuated but remained highly significant 188 
for both BMI (β:0.55 kg.m-2 [0.52, 0.57]; p=5.9x10-201) and WC (β:1.16 cm [1.09, 1.22], 189 
p=2.0x10
-254
) (Supplemental Figure 1 and Supplemental Table 6). Odds ratios for having a 190 
BMI ≥25, BMI ≥30, or being centrally obese are presented in Supplemental Table 6 and 191 
Supplemental Figure 1, and are broadly consistent: those with increased genetic risk were at 192 
increased risk of being overweight or obese in every model.   193 
Interactions between genetic profile risk score and sleep characteristic 194 
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The GPRS-obesity was not associated with sleep duration or any other sleep characteristics 195 
(data not shown; all P-values > 0.05). However, the association between GPRS-obesity and 196 
adiposity was modified by several of these sleep characteristics (Figures 1 and 2). Sleep 197 
duration significantly modified the association of GPRS-obesity with both BMI (P-198 
interaction=3.5x10
-4
) and WC (P-interaction=0.037) (Table 4). The association between 199 
GPRS and BMI was stronger for participants with both short and long sleep duration 200 
compared with those who reported normal sleep duration: 0.62 [0.56, 0.68] kg.m
-2
 and 0.84 201 
[0.61, 1.07] kg.m
-2
 per GPRS-obesity SD compared to 0.55 [0.52, 0.58] kg.m
-2
. Among 202 
participants in the lowest quartile of the GPRS-obesity, the BMI of short and long sleepers 203 
was ~0.2 kg.m
-2
 higher than that of normal sleepers, but this was not statistically significant. 204 
Among those in the highest quartile for GPRS-obesity the difference was greater: BMI was 205 
0.6 and 1.1 kg.m
-2
 higher for short and long sleepers respectively (Figure 1). Comparable 206 
results were found for WC (Figure 2 and Table 4). Similar findings were observed for day 207 
napping, shift work, nightshift work and chronotype (Figure 1 and 2 and Supplemental 208 
Tables 7-10). The association between GPRS-obesity and BMI was stronger among 209 
participants who worked shifts (β:0.70 [ 0.61, 0.78] kg.m-2 per GPRS-obesity SD versus 0.57 210 
[0.54, 0.61] kg.m
-2
 in non-shift workers), worked night shifts (β:0.70 [0.58, 0.82] kg.m-2 211 
versus 0.58 [0.54, 0.61] kg.m
-2
 in non-nightshift workers), had day naps (β:0.69 [0.56, 0.82] 212 
kg.m
-2 
versus 0.53 [0.50, 0.56] kg.m
-2
 in those who did not has day naps), and were of 213 
evening chronotype (β:0.76 [0.66, 0.86] kg.m-2 versus 0.55 [0.50, 0.60] kg.m-2 in morning 214 
chronotype). Further adjustment for potential confounders, including smoking, physical 215 
activity, sedentary behaviour, dietary factor, and sleep characteristics (when these were not 216 
used as a factor in the interaction term) did not alter any of these associations (Supplemental 217 
Tables 7-10). 218 
 219 
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DISCUSSION 220 
Main findings 221 
This study provides novel evidence that the association between genetic predisposition to 222 
obesity and actual measures of adiposity (BMI and WC) is moderated by sleep characteristics 223 
including sleep duration, chronotype, day napping, shift work, and nightshift work. 224 
Moreover, our results show that, in the UK Biobank cohort, the interaction between GPRS-225 
obesity and sleep characteristics in their effects on adiposity were independent of a range of 226 
confounders including socio-demographic factors, diet, and co-morbidities. These findings 227 
emphasise that, although obesity is partly genetically determined, lifestyle plays a major role. 228 
The effects of the genetic predisposition to obesity appear to be augmented by sleeping 229 
behaviours including short and long duration, evening chronotype, day napping, shift work, 230 
and nightshift work. In those with a high GPRS-obesity, being a short sleeper was associated 231 
with a 0.6 kg.m
-2
 higher BMI and, being long sleeper was associated with a 1.1 kg.m
-2
 BMI, 232 
compared with those with similar genetic risk but normal sleep duration. In contrast, short 233 
and long sleep duration was only associated with ~0.2 kg.m
-2
 higher BMI in those in the 234 
lowest quartile for GPRS-obesity. This means that the adverse associations of short or long 235 
sleep durations is more pronounced in those who have increased genetic predisposition to 236 
obesity, and, conversely, less pronounced in those with lower genetic predisposition. While 237 
the causality of this association cannot be ascertained from the present data, the present 238 
findings make a case for intervention studies to determine the effects of adopting healthier 239 
sleep behaviours, particularly in individuals genetically susceptible to obesity.   240 
 241 
Although no previous studies have investigated possible interaction between GPRS-obesity 242 
and sleep characteristics, there is evidence that other lifestyle behaviours including diet and 243 
physical activity modify the relationship between the genetic risk score and adiposity 244 
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outcomes (22, 23). Our results therefore extend previous evidence of gene-environment 245 
interactions by reporting the effect of several sleep-related characteristics on genetic 246 
predisposition to obesity in a large cohort, using a more extensive genetic risk profile derived 247 
from 93-SNPs previously associated with BMI. We also need to consider that there is 248 
evidence that some sleep characteristics are partially genetically determined. It has been 249 
estimated that the heritability of sleep duration is between 31% and 55%, suggesting a 250 
substantial amount of sleep need is genetically determined (24). Similarly, chronotype is also 251 
heritable as estimated by twin and family studies (12–42%), and its genetic basis has been 252 
recently defined (12, 16). Nonetheless, some of the sleep characteristics studied such as shift 253 
work and nightshift work are potentially amenable to modification, particularly at an 254 
organisation level.  255 
Furthermore, this study corroborates previous findings regarding the association between 256 
sleep characteristics and obesity. Modal sleep duration in UK Biobank was 7 hours, 257 
consistent with previous reports (25). Our observations that sleep duration (1) and other sleep 258 
characteristics including chronotype (3), day napping (26), and shift work (27) were 259 
associated with increased risk of obesity are consistent with previous reports.  260 
Strengths and limitations of the study 261 
UK Biobank provided an opportunity to test our research question in a very large cohort and 262 
the outcomes used in this study were collected using validated and standardised 263 
measurements, rather than self-report. Although misreporting of self-reported sleep 264 
characteristics is possible, it is likely to be random in nature rather than varying 265 
systematically by the exposure or outcome of interest (28). Also our results were consistent 266 
across all sleep-characteristics. Additionally, in order to reduce misreporting we excluded 267 
outliers and extreme cases (although this did not materially affect the results). Another 268 
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limitation of this study was the lack of data on the duration of some exposures such as day 269 
napping and shiftwork. Despite this, the results observed for these exposures were consistent 270 
with those seen for other sleep characteristics for which full data was available. Chronotype 271 
was assessed using a single question, rather than a more comprehensive instrument such as 272 
the Morningness-Eveningness Questionnaire (29). The Townsend score used to estimate 273 
socio-economic deprivation is an area-based proxy rather than an individual-level metric of 274 
deprivation.   275 
A limitation of the study is that the GPRS only captures a small proportion of the genetic 276 
variance in BMI. The variance explained here is 1.9%, compared with the 2.7% of variance 277 
explained by the 97 SNPs identified in the GIANT consortium’s mega-GWAS (13). This 278 
difference is not huge and probably just reflects the differences in cohort structure (single 279 
cohort vs multiple cohorts) and small biases unaccounted for in the meta-analysis 280 
methodology. In an underpowered study, the small effect size of the genetic predictor could 281 
result in type 2 error or an inflated type 1 error rate, but the effect sizes reported here suggest 282 
that the GPRS is not underpowered. A polygenic risk score (PRS) analysis explaining more 283 
of the variance in BMI may provide greater accuracy in the measurement of the interaction 284 
effects reported here, although it is likely that this will have to await even larger GWAS 285 
studies to ensure that only genuine BMI loci are included in the PRS. A further limitation is 286 
the cross-sectional nature of the study. The size and nature of the main and interaction effects 287 
found, however, are encouraging and in the case of genetic predictors, reverse causality is 288 
unlikely to be factor influencing our interpretation of the results. Future studies of the 289 
effectiveness of sleep interventions on obesity should be sufficiently powered to study the 290 
effectiveness among sub-groups defined by genetic predisposition to obesity, as well as 291 
overall effectiveness.  292 
Implications of findings 293 
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In light of the public health threat being posed by obesity and increased adiposity worldwide, 294 
(30) our findings are highly relevant for improving global health. They highlight the fact that 295 
modifiable risk factors associated with lifestyle, including sleeping behaviours, can moderate 296 
or exacerbate the effects of genetic influences on body weight, just as physical activity and 297 
diet are known to do (22, 23). Although this study was cross-sectional, the likelihood is that 298 
identification of individuals that are genetically predisposed to increased adiposity may allow 299 
targeted interventions aimed at modifying their lifestyle risk factors for obesity and its 300 
associated diseases, with increased benefits relative to less genetically predisposed 301 
individuals. The magnitude of the associations demonstrated in our study (for example, the 302 
difference in body mass between long versus normal duration sleeper in those with high 303 
GPRS-obesity was ~4.5 kg) is sufficiently large to be clinically relevant. Previous evidence 304 
on 900,000 adults from the collaborative analyses of 57 prospective studies reported that a 5 305 
kg.m
-2
 increase in BMI is associated with 30% higher all-cause mortality and 40% higher risk 306 
for CVD mortality (7). Evidence of such gene–lifestyle interactions may empower and 307 
motivate individuals to adopt healthier lifestyle and sleep-related behaviours through 308 
knowledge that such behaviour change can be effective in preventing obesity and, therefore, 309 
risk of obesity-related non-communicable diseases (31, 32). Our findings are relevant to the 310 
health and employment sectors and suggest that promoting healthy sleep should be promoted, 311 
alongside a healthy diet and physical activity, as a means of combating the obesity epidemic.  312 
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Table 1. Cohort characteristics by quartile of genetic profile risk score for obesity
 
(GPRS-obesity)
1 
  GPRS-obesity Quartiles 
 Overall Q1   
(Lowest risk) 
Q2 Q3 Q4   
(Highest risk) 
Socio-demographics      
Total, n 119,859   30,047 29,958 29,894 29,960 
Women, n (%) 63,043 (52.6) 15,950 (53.1) 15,686 (52.4) 15,726 (52.6) 15,681 (52.3) 
Age (years), mean (SD) 56.9 (7.93) 56.9 (7.93) 56.9 (7.93) 56.8 (7.95) 56.9 (7.91) 
Townsend deprivation index score, mean 
(SD) 
-1.47 (3.00) -1.49 (3.00) -1.47 (2.98) -1.46 (3.00) -1.44 (3.01) 
Townsend deprivation index Tertile, n (%) 
   Lower (Less deprived) 
   Middle 
   Higher (Most deprived) 
 
41,704 (34.8) 
40,777 (34.1) 
37,224 (31.1) 
 
10,612 (35.4) 
10,165 (33.9) 
9,224 (30.7) 
 
10,344 (34.6) 
10,296 (34.4) 
9,277 (31.0) 
 
10,429 (34.9) 
10,122 (33.9) 
9,310 (31.2) 
 
10,319 (34.5) 
10,194 (34.1) 
9,413 (31.5) 
Smoking status, n (%) 
   Never 
 
63,840 (53.4) 
 
16,304 (54.4) 
 
16,058 (53.7) 
 
15,904 (53.4) 
 
15,574 (52.1) 
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   Previous 
   Current  
41,026 (34.3) 
14,673 (12.3) 
10,049 (33.5) 
3,623 (12.1) 
10,211 (34.2) 
3,618 (12.1) 
10,272 (34.5) 
3,631 (12.2) 
10,494 (35.1) 
3,801 (12.7) 
Obesity-related markers      
BMI (kg.m
-2
), mean (SD) 27.5 (4.83) 26.7 (4.47) 27.2 (4.65) 27.7 (4.84) 28.3 (5.18) 
BMI Categories, n (%) 
   Underweight (<18.5) 
   Normal weight (18.5-24.9) 
   Overweight (25.0 to 29.9) 
   Obese (≥30.0) 
 
622 (0.5) 
38,080 (31.9) 
50,896 (42.6) 
29,932 (25.0) 
 
242 (0.8) 
11,230 (37.5) 
12,653 (42.2) 
5,834 (19.5) 
 
168 (0.6) 
9,974 (33.4) 
12,702 (42.5) 
7,040 (23.6) 
 
108 (0.4) 
9,005 (30.2) 
13,005 (43.6) 
7,691 (25.8) 
 
104 (0.4) 
7,871 (26.3) 
12,539 (42.0) 
9,367 (31.4) 
Body fat (%), mean (SD) 31.4 (8.5) 30.6 (8.4) 31.1 (8.5) 31.6 (8.5) 32.2 (8.6) 
Waist Circumference (cm), mean (SD) 90.8 (13.6) 89.0 (13.1) 90.3 (13.3) 91.2 (13.6) 92.7 (14.2) 
Central Obesity, n (%) 41,243 (34.5) 8,710 (29.0) 9,940 (33.2) 10,572 (35.4) 12,021 (40.2) 
Sleep-related characteristics      
Sleep duration, n (%) 
   Normal 7-9h 
   Short sleepers <7h  
 
88,030 (73.8)        
29,005 (24.3)      
 
22,169 (74.1) 
7,193 (24.1) 
 
22,088 (74.1) 
7,185 (24.1) 
 
21,880 (73.6) 
7,282 (24.5) 
 
21,893 (73.5) 
7,345 (24.7) 
23 
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   Long sleepers >9h 2,190 (1.8) 538 (1.8) 534 (1.8) 563 (1.9) 555 (1.9) 
Chronotype, n (%) 
   Morning 
   Evening  
 
28,605 (74.6)      
9,728 (25.4) 
 
7,083 (74.4)      
2,441 (25.6) 
 
7,017 (74.6)      
2,388 (25.4) 
 
  7,175 (75.0) 
2,394 (25.0) 
 
7,330 (74.5)      
2,505 (25.5) 
Nap during the day, n (%) 
   Never/rarely  
   Sometimes  
   Usually 
 
67,020 (55.9)     
46,254 (38.6)      
6,544 (5.5) 
 
16,975 (56.5) 
11,488 (38.3) 
1,574 (5.2) 
 
16,709 (55.8)     
11,609 (38.8) 
1,635 (5.5) 
 
16,799 (56.2) 
11,409 (38.2)      
1,672 (5.6) 
 
16,537 (55.2) 
11,748 (39.2)      
1,663 (5.6) 
Shift work, n (%) 11,429 (16.9) 2,726 (16.0) 2,872 (17.0)   2,935 (17.4) 2,896 (17.2) 
Night shift work, n (%) 5,855 (9.4) 1,390 (8.9) 1,436 (9.3) 1,526 (9.9) 1,503 (9.7) 
Physical activity      
Total PA (MET.hr.week
-1
), mean (SD) 44.9 (62.9) 44.8 (62.9) 44.6 (62.0) 45.2 (64.1) 45.2 (62.7) 
Accelerometer total PA, (milli-gravity.day
-
1
), mean (SD) 
27.8 (8.2) 27.9 (8.3) 27.8 (8.3) 27.7 (8.2) 27.6 (8.07) 
Physically active individuals, n (%) 64,679 (54.0) 16,122 (53.7) 16,279 (54.3) 16,098 (53.9) 16,180 (54.0) 
Fitness (METs), mean (SD) 8.86 (3.5) 8.88 (3.54) 8.93 (3.4) 8.88 (3.5) 8.73 (3.5) 
24 
 
24 
 
Sleep time (h.day
-1
), mean (SD) 7.17 (1.0) 7.17 (1.0) 7.17 (1.0) 7.16 (1.0) 7.17 (1.1) 
TV viewing (h.day
-1
), mean (SD) 2.86 (1.6) 2.82 (1.6) 2.85 (1.6) 2.87 (1.6) 2.90 (1.6) 
Total Sedentary Behaviour (h.day
-1
), mean 
(SD) 
5.13 (2.3) 5.08 (2.2) 5.12 (2.3) 5.14 (2.3) 5.17 (2.3) 
Dietary intake       
Total energy intake (Kcal.day
-1
), mean 
(SD) 
2170.6 (653.9) 2184.9 (662.8) 2169.3 (642.2) 2170.3 (649.4) 2158.0 (660.7) 
Alcohol intake (% of energy intake), mean 
(SD) 
5.36 (6.6) 5.42 (6.7) 5.40 (6.7) 5.29 (6.6) 5.33 (6.6) 
Vegetable intake (portions.day
-1
), mean 
(SD) 
2.68 (1.7) 2.65 (1.7) 2.68 (1.7) 2.68 (1.7) 2.70 (1.8) 
Fruit intake (portions.day
-1
), mean (SD) 2.22 (1.5) 2.19 (1.5) 2.21 (1.5) 2.23 (1.5) 2.24 (1.6) 
Processed meat intake (portions.day
-1
), 
mean (SD) 
1.91 (1.0) 1.92 (1.0) 1.91 (1.0) 1.91 (1.0) 1.91 (1.0) 
Health status       
Diabetes history, n (%) 6,290 (5.3) 1,341 (4.5) 1,456 (4.9) 1,604 (5.4) 1,889 (6.3) 
25 
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Cancer history, n (%) 9,394 (7.9) 2,423 (8.1) 2,388 (8.0) 2,273 (7.6) 2,310 (7.7) 
Cardiovascular diseases, n (%) 36,481 (30.4) 8,645 (28.8) 8,995 (30.0) 9,204 (30.8) 9,637 (32.2) 
Depression, n (%)  41,377 (34.7)   10,429 (34.9) 10,211 (34.3) 10,267 (34.5) 10,470 (35.2) 
Long-standing illness, n (%) 39,214 (33.5) 9,461 (32.2) 9,669 (33.0) 9,842 (33.7) 10,242 (35.0) 
1
Data presented as mean and SD for continuous variables and as n and % for categorical variables. MET: Metabolic equivalent; PA: physical 
activity; SD: standard deviation. Central obesity was defined as a waist circumference >88 cm for women and >102 cm for men. Physically 
active individuals were defined as those who achieve >600 METs.hr.week
-1
. Deprivation was derived using the Townsend score. A greater 
Townsend index score implies a greater degree of deprivation. 
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Table 2.  Cohort characteristics by sleep duration categories
1
 
Quintiles of  Normal sleeper Short sleeper Long sleeper 
Socio-demographics    
Total, n 88,030 29,005 2,190 
Women, n (%) 46,440 (52.8) 15,045 (51.9) 1,158 (52.9) 
Age (years), mean (SD) 56.9 (8.0) 56.7 (7.6) 58.4 (7.8) 
Townsend deprivation index score, mean (SD) -1.63 (2.9) -1.09 (3.1) -0.53 (3.4) 
Townsend deprivation index Tertile, n (%) 
   Lower (Less deprived) 
   Middle 
   Higher (Most deprived) 
 
31,888 (36·3)     
30,560 (34·8)     
25,462 (29·0) 
 
9,099 (31·4)       
9,403 (32·5) 
10,472 (36·1) 
 
593 (27·1)         
636 (29·1)         
959 (43·8) 
Smoking status, n (%) 
   Never 
   Previous 
   Current  
 
48,184 (54.9)     
29,876 (34.0) 
9,776 (11.1) 
 
14,400 (49.8)      
10,118 (35.0)       
4,388 (15.2) 
 
946 (43.3)         
838 (38.4)         
399 (18.3) 
Obesity-related markers    
27 
 
27 
 
BMI (kg.m
-2
), mean (SD) 27.3 (4.65) 28.0 (5.15) 29.3 (5.83) 
BMI Categories, n (%) 
   Underweight (<18.5) 
   Normal weight (18.5-24.9) 
   Overweight (25.0 to 29.9) 
   Obese (≥30.0) 
 
440 (0.5)      
29,112 (33.2)     
37,769 (43.0) 
20,495 (23.3) 
 
155 (0.5)       
8,363 (28.9)      
12,030 (41.6) 
8,365 (28.9) 
 
21 (1.0)         
467 (21.5)         
846 (38.9)         
840 (38.6) 
Body fat (%), mean (SD) 31.2 (8.4) 31.7 (8.8) 34.2 (8.8) 
Waist Circumference (cm) , mean (SD) 90.2 (13.3) 92.0 (14.1) 96.0 (15.3) 
Central Obesity, n (%) 28,802 (32.8) 11,008 (38.0) 1,117 (51.1) 
Sleep-related characteristic    
Chronotype, n (%) 
   Morning 
   Evening  
 
20,061 (75.1) 
6,638 (24.9) 
 
7,975 (74.5)       
2,737 (25.6) 
 
455 (60.5)         
297 (39.5) 
Nap during the day, n (%) 
   Never/rarely  
   Sometimes  
 
49,468 (56.2) 
34,029 (38.7)       
 
16,848 (58.1)      
10,863 (37.5) 
 
483 (22.1)       
1,043 (47.7)         
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   Usually 4,522 (5.1) 1,283 (4.4) 660 (30.2) 
Shift work, n (%) 7,514 (15.1) 3,712 (21.7) 143 (27.4) 
Nigh shift work, n (%) 3,669 (8.0) 2,075 (13.4) 79 (17.3) 
Physical activity    
Total PA (MET.hr.week
-1
), mean (SD) 44.5 (60.1) 47.7 (71.5) 33.5 (54.1) 
Accelerometer total PA, (milli-gravity.day
-1
), 
mean (SD) 
27.9 (8.2) 27.6 (8.3) 23.7 (7.35) 
Physically active individuals, n (%) 48,663 (55.3) 15,019 (51.) 849 (38.8) 
Fitness (METs), mean (SD) 8.99 (3.4) 8.62 (3.5) 6.98 (3.6) 
Sleep time (h.day
-1
), mean (SD) 7.56 (0.6) 5.74 (0.5) 10.4 (0.8) 
TV viewing (h.day
-1
), mean (SD) 2.79 (1.6) 2.98 (1.7) 3.83 (2.2) 
Total Sedentary Behaviour (h.day
-1
), mean 
(SD) 
5.06 (2.2) 5.33 (2.5) 5.61 (2.5) 
Dietary intake     
Total energy intake (Kcal.day
-1
), mean (SD) 2171.3 (638.2) 2170.2 (701.8) 2142.2 (691.2) 
Alcohol intake (% of energy intake), mean 5.38 (6.6) 5.34 (6.9) 4.60 (7.3) 
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(SD) 
Vegetable intake (portions.day
-1
), mean (SD) 2.69 (1.7) 2.65 (1.9) 2.70 (2.1) 
Fruit intake (portions.day
-1
), mean (SD) 2.22 (1.5) 2.23 (1.7) 2.12 (2.1) 
Processed meat intake (portions.day
-1
), mean 
(SD) 
1.90 (1.0) 1.93 (1.0) 1.99 (1.1) 
Health status     
Diabetes history, n (%) 4,255 (4.8) 1,679 (5.8) 280 (12.9) 
Cancer history, n (%) 6,858 (7.8) 2,237 (7.7) 244 (11.2) 
Cardiovascular diseases, n (%) 25,581 (29.1) 9,624 (33.2) 989 (45.2) 
Depression, n (%)  28,775 (32.9) 11,158 (38.7) 1,145 (52.9) 
Long-standing illness, n (%) 26,637 (30.1) 10,913 (38.7) 1,335 (62.6) 
1
Data presented as mean and SD for continuous variables and as n and % for categorical variables. MET: Metabolic equivalent; PA: physical 
activity; SD: standard deviation. Central obesity was defined as a waist circumference >88 cm for women and >102 cm for men. Physically 
active individuals were defined as those who achieve >600 METs.hr.week
-1
. Deprivation was derived using the Townsend score. A greater 
Townsend index score implies a greater degree of deprivation. 
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Table 3. Association between sleep characteristics and obesity-related outcomes 
 BMI ≥25.0 kg.m-2  BMI ≥30.0 kg.m
-2
  Central Obesity*  
 OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value 
Sleep duration       
Normal 1.00 (Ref.)  1.00 (Ref.)  1.00 (Ref.)  
Short Sleeper (<7 h.day
-1
) 1.13 (1.09, 1.16) <0.0001 1.24 (1.18, 1.29) <0.0001 1.14 (1.11, 1.18) <0.0001 
Long Sleeper (>9 h.day
-1
) 1.17 (1.04, 1.32) 0.012 1.23 (1.06, 1.42) 0.007 1.22 (1.10, 1.35) <0.0001 
Chronotype       
Morning 1.00 (Ref.)  1.00 (Ref.)  1.00 (Ref.)  
Evening 1.12 (1.04, 1.21) 0.003 1.15 (1.04, 1.27) 0.005 1.08 (1.01, 1.16) 0.027 
Day napping       
Never/rarely 1.00 (Ref.)  1.00 (Ref.)  1.00 (Ref.)  
Sometimes 1.21 (1.18, 1.25) <0.0001 1.33 (1.28, 1.38) <0.0001 1.26 (1.22, 1.30) <0.0001 
Usually 1.21 (1.13, 1.30) <0.0001 1.40 (1.28, 1.53) <0.0001 1.39 (1.31, 1.48) <0.0001 
Shift work        
Never/rarely 1.00 (Ref.)  1.00 (Ref.)  1.00 (Ref.)  
31 
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Sometimes/Usually 1.27 (1.20, 1.33) <0.0001 1.40 (1.30, 1.50) <0.0001 1.22 (1.16, 1.28) <0.0001 
Nightshift work        
Never/rarely 1.00 (Ref.)  1.00 (Ref.)  1.00 (Ref.)  
Sometimes/Usually 1.28 (1.19, 1.38) <0.0001 1.44 (1.31, 1.58) <0.0001 1.18 (1.10, 1.26) <0.0001 
Data presented as Odd ratio and their 95% CI. *Central obesity was defined as a waist circumference >88 cm for women and >102 cm for men. 
Models were adjusted for socio-demographics (age, sex, month of recruitment, deprivation), diabetes, depression, long-standing illness, 
cardiovascular disease, cancer, lifestyles factors (smoking, physical activity, sedentary behaviour, dietary intakes related variables including 
alcohol, fruits, coffee, vegetables, meats, processed meats, cereals, bread and cheese, and sleep characteristics (sleep duration, day napping, 
chronotype), when these ones were not used as main exposure in the models). Logistic regression performed to investigate the association 
between variables of interest.  
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Table 4.  Association between genetic profile risk score for obesity (GPRS-obesity) and BMI by sleep duration 
  Normal sleeper   Short sleeper  Long sleeper    
BMI n  (95% CI) p-value  (95% CI) p-value  (95% CI) p-value P* 
Model 0 114,983 0.55 (0.52, 0.58) 1.1x10
-292 
0.62 (0.56, 0.68) 8.2x10
-101 
0.84 (0.61, 1.07) 5.6x10
-13 
1.4x10
-4 
Model 1 101,451 0.52 (0.49, 0.55) 2.0x10
-256 
0.60 (0.54, 0.65) 1.8x10
-90 
0.73 (0.49, 0.97) 2.5x10
-9 
3.5x10
-4 
WC         
Model 0 115,139 1.18 (1.11, 1.25) 3.5x10
-212 
1.28 (1.14, 1.42) 1.7x10
-71 
1.60 (1.06, 2.15) 9.9x10
-9 
0.015
 
Model 1 101,578 1.13 (1.05, 1.21) 1.4x10
-188 
1.21 (1.07, 1.35) 1.8x10
-61 
1.40 (0.83, 1.97) 1.8x10
-6 
0.037
 
Data presented as beta coefficients (95%CI). The beta coefficient ( indicates the change in BMI (kg.m-2) and WC (cm) per 1 SD increase in 
GPRS-obesity by sleep duration. The p-value for the interaction between genetic risk score and sleep duration is presented as P*. The interaction 
between sleep characteristic and GPRS-obesity were tested using GLM analysis. 
Model 0 was adjusted for age, sex, month of recruitment, deprivation, disease history (diabetes, depression, long-standing illness, cardiovascular 
diseases, and cancer) and genetic-quality measurement.  
Model 1 was adjusted for model 0 plus smoking, physical activity, sedentary behaviour, sleep characteristics (chronotype, day napping, and 
getting up in the morning), and dietary intake variables (alcohol, fruits, coffee, vegetables, meats, processed meat, cereals, bread, and cheese). 
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Figure legends 
 
Figure 1. Interaction between GPRS-obesity and sleep characteristics in their effects on 
BMI 
Data are presented as adjusted mean and 95% CI. Models were adjusted as described in the 
Methods. In addition, each model was adjusted for the sleep characteristics (sleep duration, 
chronotype, and day napping) not being included in the interaction term for that model. The 
interaction between sleep characteristic and GPRS-obesity were tested using GLM analysis. 
*Shows significant differences between categories (P < 0.05). Number of individuals by quartile 
of GPRS-obesity and sleep characteristics are as follow: Sleep duration (Q1: 19,141/6,063/440; 
Q2: 19,073/5,990/439; Q3: 18,967/6,150/447; Q4: 18,894/6,175/451 for ‘Short’, ‘Normal’ and 
‘Long’ sleepers, respectively); Day napping (Q1: 14,658/9,746/1,307; Q2: 14,355/9,859/1,374; 
Q3: 14,522/9,758/1,383; Q4: 14,301/9,955/1,374 for ‘Never/rarely’, ‘Sometime’ and ‘Usually’ 
categories, respectively); Shift work (Q1: 12,363/2,305; Q2: 12,188/2,410; Q3: 12,045/2,497; 
Q4:12,045/2,468 for ‘Never/rarely’ and ‘Yes’ categories, respectively); Nightshift work (Q1: 
12,363/1,178; Q2: 12,188/1,197; Q3: 12,045/1,307; Q4:12,045/1,259 for ‘Never/rarely’ and 
‘Yes’ categories, respectively); Chronotype (Q1: 6,094/2,003; Q2: 6,046/1,977; Q3: 6,221/1,973; 
Q4:6,318/2,083 for ‘Morning’ and ‘Evening’ categories, respectively). 
 
 
 
Figure 2. Association between waist circumference and genetic profile risk score by sleep 
characteristics. 
Data presented as adjusted mean and their 95% CI. Models were adjusted as described in the 
Methods. In addition, each model was adjusted for the sleep characteristics (sleep duration, 
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chronotype, and day napping) not being included in the interaction term for that model. The 
interaction between sleep characteristic and GPRS-obesity were tested using GLM analysis. 
*Shows significant differences between categories (P < 0.05). Number of individuals by quartile 
of GPRS-obesity and sleep characteristics are as follow: Sleep duration (Q1: 19,158/6,072/445; 
Q2: 19,094/5,999/440; Q3: 18,984/6,161/449; Q4: 18,914/6,185/454 for ‘Short’, ‘Normal’ and 
‘Long’ sleepers, respectively); Day napping (Q1: 14,671/9,762/1,309; Q2: 14,366/9,873/1,380; 
Q3: 14,535/9,772/1,386; Q4: 14,310/9,974/1,379 for ‘Never/rarely’, ‘Sometime’ and ‘Usually’ 
categories, respectively); Shift work (Q1: 12,369/2,307; Q2: 12,198/2,412; Q3: 12,058/2,499; 
Q4:12,052/2,470 for ‘Never/rarely’ and ‘Yes’ categories, respectively); Nightshift work (Q1: 
12,369/1,181; Q2: 12,198/1,198; Q3: 12,058/1,307; Q4:12,052/1,261 for ‘Never/rarely’ and 
‘Yes’ categories, respectively); Chronotype (Q1: 6,109/2,005; Q2: 6,051/1,979; Q3: 6,227/1,977; 
Q4: 6,332/2,092 for ‘Morning’ and ‘Evening’ categories, respectively).    
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Figure 1 
  
36 
 
36 
 
 
 
Figure 2 
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Supplemental Table 1. List of the 93 SNPs used for GPRS-obesity 
SNP Chr Position Gene 
BMI-
increasing 
allele 
Other 
allele 
BMI  per 
4 kg.m
-2
 
rs1558902 16 52,361,075 FTO A T 0.0818 
rs6567160 18 55,980,115 MC4R C T 0.0556 
rs13021737 2 622,348 TMEM18 G A 0.0601 
rs10938397 4 44,877,284 GNPDA2 G A 0.0402 
rs543874 1 176,156,103 SEC16B G A 0.0482 
rs2207139 6 50,953,449 TFAP2B G A 0.0447 
rs11030104 11 27,641,093 BDNF A G 0.0414 
rs3101336 1 72,523,773 NEGR1 C T 0.0334 
rs7138803 12 48,533,735 BCDIN3D A G 0.0315 
rs10182181 2 25,003,800 ADCY3 G A 0.0307 
rs3888190 16 28,796,987 ATP2A1 A C 0.0309 
rs1516725 3 187,306,698 ETV5 C T 0.0451 
rs12446632 16 19,842,890 GPRC5B G A 0.0403 
rs2287019 19 50,894,012 QPCTL C T 0.0360 
rs16951275 15 65,864,222 MAP2K5 T C 0.0311 
rs3817334 11 47,607,569 MTCH2 T C 0.0262 
rs2112347 5 75,050,998 POC5 T G 0.0261 
rs12566985 1 74,774,781 FPGT G A 0.0242 
rs3810291 19 52,260,843 ZC3H4 A G 0.0283 
rs7141420 14 78,969,207 NRXN3 T C 0.0235 
rs13078960 3 85,890,280 CADM2 G T 0.0297 
rs10968576 9 28,404,339 LINGO2 G A 0.0249 
rs17024393 1 109,956,211 GNAT2 C T 0.0658 
rs12429545 13 53,000,207 OLFM4 A G 0.0334 
rs13107325 4 103,407,732 SLC39A8 T C 0.0477 
rs11165643 1 96,696,685 PTBP2 T C 0.0218 
rs17405819 8 76,969,139 HNF4G T C 0.0224 
rs1016287 2 59,159,129 LINC01122 T C 0.0229 
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rs4256980 11 8,630,515 TRIM66 G C 0.0209 
rs12401738 1 78,219,349 FUBP1 A G 0.0211 
rs205262 6 34,671,142 C6orf106 G A 0.0221 
rs12016871 13 26,915,782 MTIF3 T C 0.0298 
rs12940622 17 76,230,166 RPTOR G A 0.0182 
rs11847697 14 29,584,863 PRKD1 T C 0.0492 
rs2075650 19 50,087,459 TOMM40 A G 0.0258 
rs2121279 2 142,759,755 LRP1B T C 0.0245 
rs29941 19 39,001,372 KCTD15 G A 0.0182 
rs6091540 20 50,521,269 ZFP64 C T 0.0188 
rs7715256 5 153,518,086 GALNT10 G T 0.0163 
rs2176040 2 226,801,046 LOC646736 A G 0.0141 
rs657452 1 49,362,434 AGBL4 A G 0.0227 
rs12286929 11 114,527,614 CADM1 G A 0.0217 
rs7903146 10 114,748,339 TCF7L2 C T 0.0234 
rs10132280 14 24,998,019 STXBP6 C A 0.0230 
rs17094222 10 102,385,430 HIF1AN C T 0.0249 
rs7599312 2 213,121,476 ERBB4 G A 0.0220 
rs2365389 3 61,211,502 FHIT C T 0.0200 
rs2820292 1 200,050,910 NAV1 C A 0.0195 
rs12885454 14 28,806,589 PRKD1 C A 0.0207 
rs16851483 3 142,758,126 RASA2 T G 0.0483 
rs1167827 7 75,001,105 HIP1 G A 0.0202 
rs758747 16 3,567,359 NLRC3 T C 0.0225 
rs1928295 9 119,418,304 TLR4 T C 0.0188 
rs9925964
1
 16 31,037,396 KAT8 A G 0.0192 
rs11126666 2 26,782,315 KCNK3 A G 0.0207 
rs2650492 16 28,240,912 SBK1 A G 0.0207 
rs6804842 3 25,081,441 RARB G A 0.0185 
rs4740619 9 15,624,326 C9orf93 T C 0.0179 
rs13191362 6 162,953,340 PARK2 A G 0.0277 
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rs3736485 15 49,535,902 DMXL2 A G 0.0176 
rs17001654
2
 4 77,348,592 SCARB2 G C 0.0306 
rs11191560 10 104,859,028 NT5C2 C T 0.0308 
rs1528435 2 181,259,207 UBE2E3 T C 0.0178 
rs1000940 17 5,223,976 RABEP1 G A 0.0192 
rs2033529
1
 6 40,456,631 TDRG1 G A 0.0190 
rs11583200 1 50,332,407 ELAVL4 C T 0.0177 
rs9400239 6 109,084,356 FOXO3 C T 0.0188 
rs10733682 9 128,500,735 LMX1B A G 0.0174 
rs11688816 2 62,906,552 EHBP1 G A 0.0172 
rs11057405 12 121,347,850 CLIP1 G A 0.0307 
rs11727676 4 145,878,514 HHIP T C 0.0358 
rs3849570 3 81,874,802 GBE1 A C 0.0188 
rs6477694 9 110,972,163 EPB41L4B C T 0.0174 
rs7899106 10 87,400,884 GRID1 G A 0.0395 
rs2176598 11 43,820,854 HSD17B12 T C 0.0198 
rs2245368 7 76,446,079 DTX2P1 C T 0.0317 
rs17724992 19 18,315,825 PGPEP1 A G 0.0194 
rs7243357 18 55,034,299 GRP T G 0.0217 
rs1808579 18 19,358,886 C18orf8 C T 0.0167 
rs2033732 8 85,242,264 RALYL C T 0.0192 
rs1441264 13 78,478,920 MIR548A2 A G 0.0175 
rs2080454 16 47,620,091 CBLN1 C A 0.0168 
rs7164727 15 70,881,044 LOC100287559 T C 0.0180 
rs17203016 2 207,963,763 CREB1 G A 0.0210 
rs977747 1 47,457,264 TAL1 T G 0.0167 
rs9914578 17 1,951,886 SMG6 G C 0.0201 
rs9374842 6 120,227,364 LOC285762 T C 0.0187 
rs16907751 8 81,538,012 ZBTB10 C T 0.0350 
rs9540493 13 65,103,705 MIR548X2 A G 0.0172 
rs7239883 18 38,401,669 LOC284260 G A 0.0164 
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rs13201877 6 137,717,234 IFNGR1 G A 0.0233 
rs2836754 21 39,213,610 ETS2 C T 0.0164 
rs492400 2 219,057,996 USP37 C T 0.0158 
rs9641123 7 93,035,668 CALCR C G 0.0191 
rs1460676 2 164,275,935 FIGN C T 0.0197 
rs4787491 16 29,922,838 INO80E G A 0.0159 
rs6465468 7 95,007,450 ASB4 T G 0.0166 
1
 Not genotyped in UK Biobank cohort and therefore not analysed in the current report.  
2
 Excluded from the SNP set for GPRS-obesity calculation on the basis of Hardy-Weinberg equilibrium p < 10
-6
. 
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Supplemental Table 2.  Cohort characteristics by chronotype
1
 
Quintiles of  Morning  Evening 
Socio-demographics   
Total, n 28,605 9,728 
Women, n (%) 13,016 (45.5) 4,670 (48.0) 
Age (years), mean (SD) 57.7 (7.6) 55.4 (8.1) 
Townsend index score, mean (SD) -1.42 (3.0) -1.02 (3.1) 
Townsend index score Tertile, n (%) 
   Lower (Less deprived) 
   Middle 
   Higher (Most deprived) 
 
9,804 (34.3)       
9,750 (34.1)       
9,014 (31.6) 
 
2,913 (30.0)  
3,180 (32.7)       
3,624 (37.3) 
Smoking status, n (%) 
   Never 
   Previous 
   Current  
 
15,975 (56.0)      
 9,609 (33.7)       
2,922 (10.3) 
 
4,081 (42.1)       
3,502 (36.1)       
2,123 (21.9) 
Obesity-related markers   
BMI (kg.m
-2
), mean (SD) 27.7 (4.86) 28.1 (5.31) 
BMI Categories, n (%) 
   Underweight (<18.5) 
   Normal weight (18.5-24.9) 
   Overweight (25.0 to 29.9) 
   Obese (≥30.0) 
 
157 (0.6)       
8,786 (30.8)      
12,088 (42.4)       
7,485 (26.3) 
 
61 (0.63)       
2,778 (28.7)       
3,937 (40.7)       
2,910 (30.0) 
Body fat (%), mean (SD) 31.7 (8.4) 31.9 (9.0) 
Waist Circumference (cm), mean (SD) 90.8 (13.8) 92.7 (14.3) 
Central Obesity, n (%) 10,232 (35.8) 3,909 (40.3) 
Sleep-related characteristic   
Sleep duration, n (%) 
   Normal 7-9h 
   Short sleepers <7h  
   Long sleepers >9h 
 
20,061 (70.4) 
7,975 (28.0)        
 455 (1.6) 
 
6,638 (68.6)       
2,737 (28.3)         
297 (3.1) 
Nap during the day, n (%) 
   Never/rarely  
   Sometimes  
   Usually 
 
15,058 (52.7)     
11,587 (40.5)       
1,952 (6.8) 
 
5,290 (54.4)       
3,770 (38.8)         
664 (6.8) 
Shift work, n(%) 2,643 (16.9) 1,183 (20.7) 
Nigh shift work, n(%) 1,260 (8.8) 717 (13.6) 
Physical activity   
Total PA (MET.hr.week
-1
), mean (SD) 51.3 (69.0) 37.3 (55.9) 
Accelerometer total PA, (milli-gravity.day
-1
), 
mean (SD) 
28.6 (8.4) 26.1 (8.0) 
Physically active individuals, n (%) 16,456 (57.5) 4,634 (47.6) 
Fitness (METs), mean (SD) 8.82 (3.5) 8.48 (3.5) 
Sleep time (h.day
-1
), mean (SD) 7.09 (1.1) 7.12 (1.2) 
TV viewing (h.day
-1
), mean (SD) 2.87 (1.6) 2.97 (1.9) 
Total Sedentary Behaviour (h.day
-1
), mean 
(SD) 
5.09 (2.3) 5.49 (2.5) 
Dietary intake    
Total energy intake (Kcal.day
-1
), mean (SD) 2137.2 (661.3) 2219.2 (691.0) 
Alcohol intake (% of TE), mean (SD) 5.06 (6.5) 5.93 (7.5) 
Vegetable intake (portions.day
-1
), mean (SD) 2.78 (1.8) 2.62 (1.8) 
Fruit intake (portions.day
-1
), mean (SD) 2.39 (1.6) 2.00 (1.6) 
Processed meat intake (portions.day
-1
), mean 
(SD) 
1.82 (1.0) 2.00 (1.1) 
Health status    
Diabetes history, n (%) 1,560 (5.5) 682 (7.0) 
Cancer history, n (%) 2,303 (8.1) 722 (7.4) 
Cardiovascular diseases, n (%) 9,248 (32.3) 2,938 (30.2) 
Depression, n (%)  9,540 (33.6) 4,046 (41.9) 
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Long-standing illness, n (%) 9,306 (33.2) 3,873 (40.8) 
1
Data presented as mean and SD for continuous variables and as n and % for categorical variables. MET: Metabolic 
equivalent; PA: physical activity; TE: total energy; SD: standard deviation. Central obesity was defined as a waist 
circumference >88 cm for women and >102 cm for men. Physically active individuals were defined as those who 
achieve >600 METs.hr.week
-1
. Deprivation was derived using the Townsend score. A greater Townsend index score 
implies a greater degree of deprivation. 
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Supplemental Table 3.  Cohort characteristic by day napping
1
 
Quintiles of  Never/rarely Sometimes Usually 
Socio-demographics    
Total, n 67,020 46,254 6,544 
Women, n (%) 38,488 (57.4) 22,355 (48.3) 2,179 (33.3) 
Age (years), mean (SD) 55.8 (7.9) 58.1 (7.6) 59.7 (7.3) 
Townsend index score, mean (SD) -1.64 (2.9) -1.30 (3.0) -0.90 (3.2) 
Townsend index score Tertile, n (%) 
   Lower (Less deprived) 
   Middle 
   Higher (Most deprived) 
 
24,461 (36.5)     
23,154 (34.6)     
19,326 (28.9) 
 
15,330 (33.2)      
15,499 (33.6)      
15,354 (33.3) 
 
1,905 (29.1)       
2,114 (32.3)       
2,521 (38.6) 
Smoking status, n (%) 
   Never 
   Previous 
   Current  
 
38,001 (56.8)     
21,512 (32.2)       
7,352 (11.0) 
 
22,995 (49.9) 
16,896 (36.6)       
6,234 (13.5) 
 
2,821 (43.3)       
2,614 (40.1)       
1,082 (16.6) 
Obesity-related markers    
BMI (kg.m-2), mean (SD) 27.0 (4.5) 28.1 (5.0) 28.9 (5.5) 
BMI Categories, n (%) 
   Underweight (<18.5) 
   Normal weight (18.5-24.9) 
   Overweight (25.0 to 29.9) 
   Obese (≥30.0) 
 
377 (0.6)      
24,007 (35.9)     
28,119 (42.0)     
14,376 (21.5) 
 
209 (0.5)      
12,557 (27.2)      
20,043 (43.5)      
13,304 (28.9) 
 
36 (0.6)       
1,508 (23.2)       
2,718 (41.8)       
2,238 (34.4) 
Body fat (%), mean (SD) 31.2 (8.49) 31.7 (8.60) 30.9 (8.53) 
Waist Circumference (cm), mean (SD) 88.7 (13.0) 92.9 (13.7) 97.2 (14.4) 
Central Obesity, n (%) 20,107 (30.0) 18,156 (39.3) 2,960 (45.4) 
Sleep-related characteristic    
Sleep duration, n (%) 
   Normal 7-9h 
   Short sleepers <7h  
   Long sleepers >9h 
 
49,468 (74.1) 
16,848 (25.2) 
483 (0.7) 
 
34,029 (74.1)      
10,863 (23.7)       
1,043 (2.3) 
 
4,522 (70.0)       
1,283 (19.9)         
660 (10.2) 
Chronotype, n (%) 
   Morning 
   Evening  
 
15,058 (74.0)       
5,290 (26.0) 
 
11,587 (75.5)       
3,770 (24.6) 
 
1,952 (74.6) 
664 (25.4) 
Shift work, n(%) 5,776 (13.8) 5,030 (21.5) 619 (25.3) 
Nigh shift work, n(%) 2,794 (7.2) 2,721 (12.9) 337 (15.5) 
Physical activity    
Total PA (MET.hr.week-1), mean (SD) 45.4 (63.0) 44.4 (62.6) 44.6 (64.3) 
Accelerometer total PA, (milli-gravity.day-1), mean 
(SD) 
28.6 (8.2) 26.7 (8.0) 25.4 (8.0) 
Physically active individuals, n (%) 37,289  (55.6) 24,146 (52.2) 3,233 (49.4) 
Fitness (METs), mean (SD) 9.07 (3.4) 8.64 (3.5) 8.13 (3.8) 
Sleep time (h.day-1), mean (SD) 7.07 (0.9) 7.23 (1.1) 7.70 (1.5) 
TV viewing (h.day-1), mean (SD) 2.63 (1.5) 3.11 (1.7) 3.53 (2.1) 
Total Sedentary Behaviour (h.day-1), mean (SD) 4.92 (2.2) 5.35 (2.3) 5.76 (2.6) 
Dietary intake     
Total energy intake (Kcal.day-1), mean (SD) 2133.6 (634.9) 2211.3 (670.0) 2322.1 (719.5) 
Alcohol intake (% of TE), mean (SD) 5.55 (6.8) 5.09 (6.5) 5.18 (6.8) 
Vegetable intake (portions.day-1), mean (SD) 2.67 (1.7) 2.68 (1.8) 2.70 (1.9) 
Fruit intake (portions.day-1), mean (SD) 2.24 (1.5) 2.19 (1.6) 2.14 (1.7) 
Processed meat intake (portions.day-1), mean (SD) 1.83 (1.0) 1.99 (1.0) 2.15 (1.1) 
Health status     
Diabetes history, n (%) 2,337 (3.5) 3,213 (7.0) 735 (11.3) 
Cancer history, n (%) 4,914 (7.4) 3,863 (8.4) 615 (9.4) 
Cardiovascular diseases, n (%) 17,266 (25.8) 16,243 (35.1) 2,957 (45.2) 
Depression, n (%)  21,466 (32.2) 17,234 (37.5) 2,666 (41.0) 
Long-standing illness, n (%) 18,257 (27.8) 17,514 (38.8) 3,427 (53.7) 
1
Data presented as mean and SD for continuous variables and as n and % for categorical variables. MET: Metabolic 
equivalent; PA: physical activity; TE: total energy; SD: standard deviation. Central obesity was defined as a waist 
circumference >88 cm for women and >102 cm for men. Physically active individuals were defined as those who 
achieve >600 METs.hr.week
-1
. Deprivation was derived using the Townsend score. A greater Townsend index score 
implies a greater degree of deprivation.  
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Supplemental Table 4.  Cohort characteristic by shift work
1
 
Quintiles of  Never/rarely Sometimes/Usually 
Socio-demographics   
Total, n 56,247 11,429 
Women, n (%) 29,053 (51.7) 5,035 (44.1) 
Age (years), mean (SD) 53.2 (7.0) 52.1 (6.9) 
Townsend index score, mean (SD) -1.65 (2.8) -0.86 (3.1) 
Townsend index score Tertile, n (%) 
   Lower (Less deprived) 
   Middle 
   Higher (Most deprived) 
 
20,301 (36.1)     
19,590 (34.9)     
16,281 (29.0) 
 
3,151 (27.6) 
3,721 (32.6)       
4,537 (40.0) 
Smoking status, n (%) 
   Never 
   Previous 
   Current  
 
32,206 (57.4)     
17,538 (31.3)       
6,386 (11.4) 
 
5,580 (48.9)       
3,695 (32.4)       
2,133 (18.7) 
Obesity-related markers   
BMI (kg.m-2), mean (SD) 27.2 (4.69) 28.2 (5.00) 
BMI Categories, n (%) 
   Underweight (<18.5) 
   Normal weight (18.5-24.9) 
   Overweight (25.0 to 29.9) 
   Obese (≥30.0) 
 
260 (0.5)      
19,299 (34.4) 
23,691 (42.2)     
12,887 (23.0) 
 
43 (0.4)    
3,076 (27.0) 
4,886 (42.8)       
3,407 (29.9) 
Body fat (%), mean (SD) 30.4 (8.5) 30.4 (8.5) 
Waist Circumference (cm), mean (SD) 89.7 (13.4) 92.7 (13.9) 
Central Obesity, n(%) 17,177 (30.1) 4,212 (36.9) 
Sleep-related characteristic   
Sleep duration, n (%) 
   Normal 7-9h 
   Short sleepers <7h  
   Long sleepers >9h 
 
42,337 (75.4) 
13,413 (23.9) 
379 (0.7) 
 
7,514 (66.1) 
3,712 (32.7) 
143 (1.3) 
Chronotype, n (%) 
   Morning 
   Evening  
 
13,036 (74.1) 
4,547 (25.9) 
 
2,643 (69.1)       
1,183 (31.0) 
Nap during the day, n (%) 
   Never/rarely  
   Sometimes  
   Usually 
 
36,023 (64.1) 
18,387 (32.7) 
1,832 (3.3) 
 
5,776 (50.6) 
5,030 (44.0) 
619 (5.42) 
Physical activity   
Total PA (MET.hr.week-1), mean (SD) 42.7 (62.1) 69.0 (95.1) 
Accelerometer total PA, (milli-gravity.day-1), mean 
(SD) 
28.9 (8.3) 29.2 (8.7) 
Physically active individuals, n (%) 29,537 (52.5) 6,718 (58.8) 
Fitness (METs), mean (SD) 9.63 (3.3) 9.52 (3.2) 
Sleep time (h.day-1), mean (SD) 7.08 (0.9) 6.94 (1.0) 
TV viewing (h.day-1), mean (SD) 2.42 (1.3) 2.70 (1.5) 
Total Sedentary Behaviour (h.day-1), mean (SD) 4.94 (2.3) 5.49 (2.7) 
Dietary intake    
Total energy intake (Kcal.day-1), mean (SD) 2167.4 (644.5) 2234.8 (724.4) 
Alcohol intake (% of TE), mean (SD) 5.59 (6.7) 5.34 (7.2) 
Vegetable intake (portions.day-1), mean (SD) 2.59 (1.7) 2.55 (1.7) 
Fruit intake (portions.day-1), mean (SD) 2.22 (1.5) 2.10 (1.7) 
Processed meat intake (portions.day-1), mean (SD) 1.89 (1.1) 2.04 (1.1) 
Health status    
Diabetes history, n (%) 1,958 (3.5) 492 (4.3) 
Cancer history, n (%) 3,271 (5.8) 567 (5.0) 
Cardiovascular diseases, n (%) 12,870 (22.9) 2,847 (24.9) 
Depression, n (%)  18,292 (32.7) 3,898 (34.3) 
Long-standing illness, n (%) 13,969 (25.3) 3,221 (28.9) 
1
Data presented as mean and SD for continuous variables and as n and % for categorical variables. MET: Metabolic 
equivalent; PA: physical activity; TE: total energy; SD: standard deviation. Central obesity was defined as a waist 
circumference >88 cm for women and >102 cm for men. Physically active individuals were defined as those who 
achieve >600 METs.hr.week
-1
. Deprivation was derived using the Townsend score. A greater Townsend index score 
implies a greater degree of deprivation. 
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Supplemental Table 5.  Cohort characteristic by nightshift work
1
 
Quintiles of  Never/rarely Sometimes/Usually 
Socio-demographics   
Total n 56,247 5,855 
Women, n (%) 29,053 (51.7) 2,142 (36.6) 
Age (years), mean (SD) 53.2 (7.0) 51.5 (6.7) 
Townsend index score, mean (SD) -1.65 (2.8) -0.86 (3.1) 
Townsend index score Tertile, n (%) 
   Lower (Less deprived) 
   Middle 
   Higher (Most deprived) 
 
20,301 (36.1)     
19,590 (34.9)     
16,281 (29.0) 
 
1,623 (27.8)       
1,906 (32.6)       
2,318 (39.6) 
Smoking status, n (%) 
   Never 
   Previous 
   Current  
 
32,206 (57.4)     
17,538 (31.3)       
6,386 (11.4) 
 
2,792 (47.8)       
1,839 (31.5)       
1,212 (20.7) 
Obesity-related markers   
BMI (kg.m-2), mean (SD) 27.2 (4.69) 28.4 (4.95) 
BMI Categories, n (%) 
   Underweight (<18.5) 
   Normal weight (18.5-24.9) 
   Overweight (25.0 to 29.9) 
   Obese (≥30.0) 
 
260 (0.5)      
19,299 (34.4)     
23,691 (42.2) 
12,887 (23.0) 
 
16 (0.3)       
1,467 (25.1)       
2,522 (43.2)       
1,839 (31.5) 
Body fat (%), mean (SD) 30.4 (8.5) 29.7 (8.38) 
Waist Circumference (cm), mean (SD) 89.7 (13.4) 93.7 (13.8) 
Central Obesity, n(%) 17,177 (30.6)   2,136 (36.5) 
Sleep-related characteristic   
Sleep duration, n (%) 
   Normal 7-9h 
   Short sleepers <7h  
   Long sleepers >9h 
 
42,337 (75.4) 
13,413 (23.9) 
379 (0.7) 
 
3,669 (63.0)       
2,075 (35.6)          
79 (1.4) 
Chronotype, n (%) 
   Morning 
   Evening  
 
13,036 (74.1) 
4,547 (25.9) 
 
1,260 (63.7) 
717 (36.3) 
Nap during the day, n (%) 
   Never/rarely  
   Sometimes  
   Usually 
 
36,023 (64.1) 
18,387 (32.7)       
1,832 (3.3) 
 
2,794 (47.7)       
2,721 (46.5) 
337 (5.8) 
Physical activity   
Total PA (MET.hr.week-1), mean (SD) 42.7 (62.1) 74.2 (99.3) 
Accelerometer total PA, (milli-gravity.day-1), mean 
(SD) 
28.9 (8.3) 29.3 (8.9) 
Physically active individuals, n (%) 29,537 (52.5) 3,601 (61.5) 
Fitness (METs), mean (SD) 9.63 (3.3) 9.66 (3.1) 
Sleep time (h.day-1), mean (SD) 7.08 (0.9) 6.88 (1.1) 
TV viewing (h.day-1), mean (SD) 2.42 (1.3) 2.75 (1.5) 
Total Sedentary Behaviour (h.day-1), mean (SD) 4.94 (2.3) 5.69 (2.8) 
Dietary intake    
Total energy intake (Kcal.day-1), mean (SD) 2167.4 (644.5) 2274.7 (739.4) 
Alcohol intake (% of TE), mean (SD) 5.59 (6.7) 5.40 (7.3) 
Vegetable intake (portions.day-1), mean (SD) 2.59 (1.7) 2.51 (1.7) 
Fruit intake (portions.day-1), mean (SD) 2.22 (1.5) 2.08 (1.7) 
Processed meat intake (portions.day-1), mean (SD) 1.89 (1.1) 2.11 (1.0) 
Health status    
Diabetes history, n (%) 1,958 (3.5) 248 (4.3) 
Cancer history, n (%) 3,271 (5.8) 264 (4.5) 
Cardiovascular diseases, n (%) 12,870 (22.9) 1,450 (24.8) 
Depression, n (%)  18,292 (32.7) 1,899 (32.7) 
Long-standing illness, n (%) 13,969 (25.3) 1,638 (28.7) 
1
Data presented as mean and SD for continuous variables and as n and % for categorical variables. MET: Metabolic 
equivalent; PA: physical activity; TE: total energy; SD: standard deviation. Central obesity was defined as a waist 
circumference >88 cm for women and >102 cm for men. Physically active individuals were defined as those who 
achieve >600 METs.hr.week
-1
. Deprivation was derived using the Townsend score. A greater Townsend index score 
implies a greater degree of deprivation. 
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Supplemental Table 6. Association of genetic profile risk score with BMI and waist circumference
1 
 
  Model 0   Model 1  
 n Beta (95% CI) p-value n Beta (95% CI) p-value 
BMI (kg.m-2) 115,517 0.57 (0.55, 0.60) 6.3x10
-207 101,859 0.55 (0.52, 0.57) 5.9x10-201 
WC (cm) 115,675 1.21 (1.15, 1.28) 4.2x10
-289 101,986 1.16 (1.09, 1.22) 2.0x10-254 
 n Odds ratio (95% CI) p-value n Odds ratio (95% CI) p-value 
BMI ≥25.0 115,517 1.22 (1.21, 1.24) 3.5x10
-197 101,859 1.22 (1.21, 1.24) 3.2x10-193 
BMI ≥30.0 65,655 1.38 (1.35, 1.40) 9.4x10
-321 58,121 1.39 (1.36, 1.42) 8.5x10-317 
Central obesity 115,675 1.20 (1.18, 1.21) 4.4x10
-401 101,986 1.20 (1.18, 1.22) 4.0x10-397 
1
Data presented as beta coefficients or odd ratio
 
and the corresponding 95%CI. The beta coefficient indicates the change in BMI in kg.m
-2
 per or in WC in cm per 1 SD 
increase in the genetic risk score. The OR indicates the odds ratio for extra risk of having BMI ≥25.0 kg.m-2 or BMI ≥30.0 kg.m-2 or central obese (WC ≥88 for females and 
≥102 for males) per SD increase in GPRS.  
Model 0 was adjusted for age, sex, month of recruitment, disease history (deprivation, diabetes, depression, long-standing illness, CVDs, and cancer) and genetic-quality 
measurement.  
Model 1 was adjusted for model 0 plus smoking, physical activity, sedentary behaviour, sleep characteristic (sleep duration, chronotype, day napping, and getting up in the 
morning), and dietary intake variables (alcohol, fruits, coffee, vegetables, meats, processed meat, cereals, bread, and cheese). 
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Supplemental Table 7.  Association between genetic profile risk score and BMI by Chronotype
1
 
  Morning  Evening   
BMI n B (95% CI) p-value B (95% CI) p-value P* 
Model 0 36,943 0.55 (0.50, 0.60) 1.2x10-88 0.76 (0.66, 0.86) 6.6x10-49 7.0x10-5  
Model 1 32,540 0.52 (0.47, 0.57) 5.1x10-77 0.72 (0.61, 0.82) 1.9x10-41 5.0x10-4 
WC       
Model 0 37,016 1.13 (1.00, 1.27) 9.6x10-61 1.53 (1.28, 1.78) 1.0x10-33 0.002 
Model 1 32,598 1.08 (0.94, 1.22) 4.1x10-53 1.45 (1.20, 1.71) 1.1x10-28 0.005 
1
Data presented as beta coefficients (95%CI). The beta coefficient indicates the change in BMI/WC by 1 SD increase in the genetic risk score by chronotype. The p-value for 
the interaction between genetic risk score and chronotype is presented as P*. 
Model 0 was adjusted for age, sex, month of recruitment, smoking, deprivation, disease history (diabetes, depression, long-standing illness, CVDs, and cancer), and genetic-
quality measurement.  
Model 1 was adjusted for model 0 plus smoking, physical activity, sedentary behaviour, sleep characteristic (sleep duration, day napping, and getting up in the morning), and 
dietary intake variables (alcohol, fruits, coffee, vegetables, meats, processed meat, cereals, bread, and cheese). 
 
 
 
 
Supplemental Table 8. Association between genetic profile risk score and BMI by day napping
1
 
  Never/rarely  Sometimes     Usually   
BMI n B (95% CI) p-value B (95% CI) p-value B (95% CI) p-value P* 
Model 0 115,489 0.53 (0.50, 0.56) 2.7x10-211 0.62 (0.58, 0.66) 6.9x10-171 0.69 (0.56, 0.82) 1.7x10-26 5.5x10-5 
Model 1 101,842 0.51 (0.48, 0.55) 8.0x10-193 0.58 (0.54, 0.63) 1.4x10-145 0.65 (0.52, 0.78) 1.0x10-22 0.002 
WC         
Model 0 115,646 1.13 (1.04, 1.21) 5.4x10-151 1.29 (1.18, 1.39) 2.1x10-121 1.49 (1.17, 1.80) 1.9x10-20 9.4x10-4 
Model 1 101,969 1.10 (1.01, 1.18) 1.1x10-137 1.22 (1.11, 1.33) 5.7x10-104 1.40 (1.08, 1.72) 1.2x10-17 0.011 
1
Data presented as beta coefficients (95%CI). The beta coefficient indicates the change in BMI/WC by 1 SD increase in the genetic risk score by day napping. The p-value 
for the interaction between genetic risk score and day napping is presented as P*. 
Model 0 was adjusted for age, sex, month of recruitment, smoking, disease history (deprivation, diabetes, depression, long-standing illness, CVDs, and cancer), and genetic-
quality measurement.  
Model 1 was adjusted for model 0 plus smoking, physical activity, sedentary behaviour, sleep characteristic (sleep duration, chronotype, and getting up in the morning) and 
dietary intake variables (alcohol, fruits, coffee, vegetables, meats, processed meat, cereals, bread, and cheese). 
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Supplemental Table 9.  Association between genetic profile risk score and BMI by shift work
1
 
  Never/ Rarely  Yes  P* 
BMI n B (95% CI) p-value B (95% CI) p-value p-interaction 
Model 0 65,491 0.57 (0.54, 0.61) 1.5x10-199 0.70 (0.61, 0.78) 1.1x10-53 0.006 
Model 1 57,647 0.54 (0.51, 0.58) 1.7x10-175 0.68 (0.59, 0.77) 1.1x10-49 0.007 
WC       
Model 0 65,550 1.18 (1.09, 1.28) 2.1x10-137 1.57 (1.35, 1.79) 5.3x10-44 9.4x10-4 
Model 1 57,694 1.13 (1.03, 1.22) 1.6x10-119 1.49 (1.27, 1.72) 2.0x10-38 0.004 
1
Data presented as beta coefficients (95%CI). The beta coefficient indicates the change in BMI by 1 SD increase in the genetic risk score by shift work. The p-value for the 
interaction between genetic risk score and shift work is presented as P*. 
Model 0 was adjusted for age, sex, month of recruitment, smoking, disease history (deprivation, diabetes, depression, long-standing illness, CVDs, and cancer), and genetic-
quality measurement.  
Model 1 was adjusted for model 0 plus smoking, physical activity, sedentary behaviour, sleep characteristic (sleep duration, chronotype, getting up in the morning, and day 
napping), and dietary intake variables (alcohol, fruits, coffee, vegetables, meats, processed meat, cereals, bread, and cheese). 
 
 
 
Supplemental Table 10.  Association between genetic profile risk score and BMI by nightshift work
1
 
  Never/rarely  Yes   
BMI n B (95% CI) p-value B (95% CI) p-value P* 
Model 0 60,138 0.58 (0.54, 0.61) 1.5x10-199 0.70 (0.58, 0.82) 1.9x10-28 0.054 
Model 1 52,976 0.55 (0.51, 0.58) 1.7x10-175 0.69 (0.56, 0.82) 8.4x10-27 0.039 
WC       
Model 0 60,194 1.18 (1.09, 1.28) 2.1x10-137 1.61 (1.30, 1.91) 3.5x10-24 0.009 
Model 1 53,020 1.13 (1.03, 1.22) 1.6x10-119 1.54 (1.22, 1.86) 1.8x10-21 0.018 
1
Data presented as beta coefficients (95%CI). The beta coefficient indicates the change in BMI/WC by 1 SD increase in the genetic risk score by nightshift work. The p-value 
for the interaction between genetic risk score and nightshift work is presented as P*. 
Model 0 was adjusted for age, sex, month of recruitment, smoking, disease history (deprivation, diabetes, depression, long-standing illness, CVDs, and cancer), and genetic-
quality measurement.  
Model 1 was adjusted for model 0 plus smoking, physical activity, sedentary behaviour, sleep characteristic (sleep duration, chronotype, getting up in the morning, and day 
napping), and dietary intake variables (alcohol, fruits, coffee, vegetables, meats, processed meat, cereals, bread, and cheese). 
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Supplemental Figure 1. BMI, waist circumference and obesity prevalence by quartile of Genetic Profile Risk 
Score 
Data are presented as adjusted mean for Figure A and B or Odds ratio and 95%CI for Figure C and D. Models were 
adjusted as described in the Methods. OR (Trend) indicates the linear estimate of the odds ratio increase per quartile 
of the genetic profile risk score. This trend test was performed using GLM analysis for continuous variables (Figure 
A and B) and with logistic regression for outcomes on Figure C and D, the Q1 (lowest genetic risk score) was used 
as the referent group for the OR analysis. Obesity (Figure C) was defined as a BMI ≥30.0 and central obesity 
(Figure D) was defined as a WC >88 cm for women and >102 cm for men.  
 
 
 
 
 
